激素治疗能够降低重症COVID-19患者病死率?结论尚早

Can critically ill patients with COVID-19 benefit from systemic corticosteroids?Too early to draw conclusions

糖皮质激素在新型冠状病毒肺炎(COVID-19)治疗中的应用备受关注,多项关于COVID-19中激素应用的临床研究结果依次发布,结合目前研究进展,谨慎、全面地解读研究结果,对于指导临床应用具有重要意义。

The administration of corticosteroids during COVID-19 pandemic has been on a debate.Since the results of the studies on corticosteroids for COVID-19 have been published,thorough and comprehensive interpretation of these results is of great significance for future clinical applications。